Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cervical Cancer

Free Subscription Articles published in Eur J Gynaecol Oncol Retrieve available abstracts of 64 articles: HTML format Text format

Single Articles

January 2016
1. YAO YY, Wang Y, Wang JL, Zhao C, et al
   Outcomes of fertility and pregnancy in patients with early-stage cervical cancer after undergoing neoadjuvant chemotherapy.
   Eur J Gynaecol Oncol. 2016;37:109-12.
   PubMed     Text format     Abstract available
   
   
   
2. CHEN XP, Xu WH, Xu DF, Fu SM, et al
   G12V Kras mutations in cervical cancer under virtual microscope of molecular dynamics simulations.
   Eur J Gynaecol Oncol. 2016;37:69-74.
   PubMed     Text format     Abstract available
   
   
   
3. ZHIQIANG L, Bin S, Min F, Yufang L, et al
   Leiomyosarcoma of cervical stump following subtotal hysterectomy: a case report and review of literature.
   Eur J Gynaecol Oncol. 2016;37:148-51.
   PubMed     Text format     Abstract available
   
   
   
4. ANTHUENIS J, Baekelandt J, Bourgain C, De Rop C, et al
   Squamous cell carcinoma in situ lining the uterine cavity.
   Eur J Gynaecol Oncol. 2016;37:135-8.
   PubMed     Text format     Abstract available
   
   
   
5. TUNC SY, Onan MA, Turp AB, Kusvuran ED, et al
   Prevalence and types of cervical human papillomavirus among Turkish women and its relationship with demographic factors in a gynecology outpatient clinic.
   Eur J Gynaecol Oncol. 2016;37:53-8.
   PubMed     Text format     Abstract available
   
   
   
6. NOOIJ LS, Kagie MJ
   'See and treat' approach for high-grade squamous intraepithelial cervical lesions.
   Eur J Gynaecol Oncol. 2016;37:22-5.
   PubMed     Text format     Abstract available
   
   
   
7. CHENG YX, Zhang QF, Pan F, Huang JL, et al
   Hydroxycamptothecin shows antitumor efficacy on HeLa cells via autophagy activation mediated apoptosis in cervical cancer.
   Eur J Gynaecol Oncol. 2016;37:238-43.
   PubMed     Text format     Abstract available
   
   
   
8. JONSKA-GMYREK J, Zolciak-Siwinska A, Gmyrek L
   Can the histopathology influence the outcome of early-stage cervical cancer?
   Eur J Gynaecol Oncol. 2016;37:178-81.
   PubMed     Text format     Abstract available
   
   
   
9. CHENG J, Dul Qx, Zhang, Ren Yf, et al
   Study on the relationship between the structure and functions of anti-human cervical cancer single-chain antibody and the lengths of linkers.
   Eur J Gynaecol Oncol. 2016;37:171-7.
   PubMed     Text format     Abstract available
   
   
   
10. MCKIM A, Walter AC, Sheely KM, Manahan KJ, et al
    An economic analysis of cisplatin alone versus cisplatin doublets in the treatment of women with advanced or recurrent cervical cancer.
    Eur J Gynaecol Oncol. 2016;37:353-6.
    PubMed     Text format     Abstract available
    
    
    
11. SUN F, Wang XJ, Ma ZB, Cai MY, et al
    Pattern of distribution and metastasis of deep obturator and parametrial lymph nodes in early stage cervical cancer patients.
    Eur J Gynaecol Oncol. 2016;37:332-7.
    PubMed     Text format     Abstract available
    
    
    
12. YEO MK, Choi SY, Kim M, Kim KH, et al
    Malignant mesonephric tumor of the cervix with an initial manifestation as pulmonary metastasis: case report and review of the literature.
    Eur J Gynaecol Oncol. 2016;37:270-7.
    PubMed     Text format     Abstract available
    
    
    
13. GIORDANO G, Manuguerra R, Varotti E, Brigati F, et al
    A case of placental site nodule associated with cervical high-grade squamous intraepithelial lesion.
    Eur J Gynaecol Oncol. 2016;37:259-61.
    PubMed     Text format     Abstract available
    
    
    
14. DEXEUS S, Dexeus D, Lugo F
    Possible relation between borderline ovarian cancer and endocervical adenocarcinoma: case report.
    Eur J Gynaecol Oncol. 2016;37:258.
    PubMed     Text format     Abstract available
    
    
    
15. OZTURK M, Umudum H, Aydin A, Ulubay M, et al
    Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test.
    Eur J Gynaecol Oncol. 2016;37:232-7.
    PubMed     Text format     Abstract available
    
    
    
16. WU H, Zhang J, Shi H
    Expression of cancer stem markers could be influenced by silencing of p16 gene in HeLa cervical carcinoma cells.
    Eur J Gynaecol Oncol. 2016;37:221-5.
    PubMed     Text format     Abstract available
    
    
    
17. WU Y, Yu D, Bai XL, Zhu W, et al
    MRI in the synchronic chemoradiotherapy of cervical squamous cell carcinoma.
    Eur J Gynaecol Oncol. 2016;37:380-3.
    PubMed     Text format     Abstract available
    
    
    
18. HASEGAWA K, Torii Y, Kato R, Udagawa Y, et al
    The problems of cervical conization for postmenopausal patients.
    Eur J Gynaecol Oncol. 2016;37:327-31.
    PubMed     Text format     Abstract available
    
    
    January 2015
19. YANG L, He Z, Huang XY, Liu HN, et al
    Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.
    Eur J Gynaecol Oncol. 2015;36:73-7.
    PubMed     Text format     Abstract available
    
    
    
20. KERIMOGLU OS, Pekin A, Yilmaz SA, Bakbak BB, et al
    Pyometra in elderly post-menopausal women: a sign of malignity.
    Eur J Gynaecol Oncol. 2015;36:59-61.
    PubMed     Text format     Abstract available
    
    
    
21. ANDRIKOPOULOU M, Salakos N, Deligeoroglou E, Pafiti A, et al
    The role of mTOR signaling pathway in premalignant and malignant cervical lesions.
    Eur J Gynaecol Oncol. 2015;36:36-43.
    PubMed     Text format     Abstract available
    
    
    
22. SHOU H, Chen Y, Chen Z, Zhu T, et al
    Laparoscopic ovarian transposition in young women with cervical squamous cell carcinoma treated by primary pelvic irradiation.
    Eur J Gynaecol Oncol. 2015;36:25-9.
    PubMed     Text format     Abstract available
    
    
    
23. YE N, Liu C, Shi P
    Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy.
    Eur J Gynaecol Oncol. 2015;36:174-80.
    PubMed     Text format     Abstract available
    
    
    
24. XING J, Wang H, Xu S, Han P, et al
    Sensitization of suberoylanilide hydroxamic acid (SAHA) on chemoradiation for human cervical cancer cells and its mechanism.
    Eur J Gynaecol Oncol. 2015;36:117-22.
    PubMed     Text format     Abstract available
    
    
    
25. QI Z, Zhang Y
    Rare case of concurrent severe chylous ascites after radical surgery for cervical cancer.
    Eur J Gynaecol Oncol. 2015;36:356-8.
    PubMed     Text format     Abstract available
    
    
    
26. ZHAO J, Wang Q, Li J, Si TB, et al
    Comparative study of phosphorylated histone H2AX expressions in the cervical cancer patients of pre- and post-neoadjuvant chemotherapy. .
    Eur J Gynaecol Oncol. 2015;36:318-22.
    PubMed     Text format     Abstract available
    
    
    
27. KANAYAMA T, Mabuchi S, Shimura K, Hisamatsu T, et al
    Prognostic factors for survival in cervical cancer patients with bone metastasis.
    Eur J Gynaecol Oncol. 2015;36:290-3.
    PubMed     Text format     Abstract available
    
    
    
28. YU C, Zhu W, Ji Y, Guo J, et al
    A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer.
    Eur J Gynaecol Oncol. 2015;36:278-82.
    PubMed     Text format     Abstract available
    
    
    
29. GARRIDO JL
    30 years of preventive studies of uterine cervical cancer 1982-2012.
    Eur J Gynaecol Oncol. 2015;36:252-4.
    PubMed     Text format     Abstract available
    
    
    
30. YIN ZM, Yu AJ, Wu MJ, Fang J, et al
    Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
    Eur J Gynaecol Oncol. 2015;36:326-9.
    PubMed     Text format     Abstract available
    
    
    
31. GARRIDO JL
    30 years of colposcopic studies: validity of local destructives treatments.
    Eur J Gynaecol Oncol. 2015;36:323-5.
    PubMed     Text format     Abstract available
    
    
    
32. CHENG Y, Ma D, Zhang Y, Li Z, et al
    Cervical squamous cancer mRNA profiles reveal the key genes of metastasis and invasion.
    Eur J Gynaecol Oncol. 2015;36:309-17.
    PubMed     Text format     Abstract available
    
    
    
33. RUANO Y, Torrents M, Ferrer FJ
    Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
    Eur J Gynaecol Oncol. 2015;36:245-51.
    PubMed     Text format     Abstract available
    
    
    
34. CAPILNA ME, Rusu SC, Puiac CI, Daniilidis A, et al
    Spontaneous intrauterine pregnancy following abdominal radical trachelectomy--a case report.
    Eur J Gynaecol Oncol. 2015;36:229-30.
    PubMed     Text format     Abstract available
    
    
    
35. DONATI P, Paolino G, Donati M, Panetta C, et al
    Adenocarcinoma of the cervix associated with a neuroendocrine small cell carcinoma of the cervix in the spectrum of Muir-Torre syndrome.
    Eur J Gynaecol Oncol. 2015;36:213-5.
    PubMed     Text format     Abstract available
    
    
    
36. NAKAYAMA Y, Yamada M, Kurata A, Kiseki H, et al
    Evaluation of the human papillomavirus mRNA test for the detection of cervical lesions in Japan.
    Eur J Gynaecol Oncol. 2015;36:192-6.
    PubMed     Text format     Abstract available
    
    
    
37. DEMIRTAS GS, Akman L, Demirtas O, Hursitoglu BS, et al
    Clinical significance of ASCUS and ASC-H cytological abnormalities: a six-year experience at a single center.
    Eur J Gynaecol Oncol. 2015;36:150-4.
    PubMed     Text format     Abstract available
    
    
    
38. SAKANO CR, Ribalta JC, Zucchi P
    Tracking of cervical cancer in 7,519 patients: a study of the prevalence of altered cytologies.
    Eur J Gynaecol Oncol. 2015;36:437-41.
    PubMed     Text format     Abstract available
    
    
    
39. PEREIRA ER, Speck NM, Rodrigues DA, De Freitas VG, et al
    Prevention, diagnosis and treatment of cervical cancer precursor lesions at the Xingu Indigenous Park, Brazil.
    Eur J Gynaecol Oncol. 2015;36:376-82.
    PubMed     Text format     Abstract available
    
    
    
40. ZHANG F, Yu Y, Song S, Wang M, et al
    Calcitriol does not significantly enhance the efficacy of radiation of human cervical tumors in mice.
    Eur J Gynaecol Oncol. 2015;36:452-6.
    PubMed     Text format     Abstract available
    
    
    
41. FEI H, Ke P, Wang N, Shen H, et al
    An evaluation comparing Californium252 neutron brachytherapy with neoadjuvant intra-arterial embolism chemotherapy assisted surgery effect for treating advanced cervical carcinoma patients.
    Eur J Gynaecol Oncol. 2015;36:442-6.
    PubMed     Text format     Abstract available
    
    
    
42. LIN F, Wang P, Shen Y, Xie X, et al
    Upregulation of microRNA-224 sensitizes human cervical cells SiHa to paclitaxel.
    Eur J Gynaecol Oncol. 2015;36:432-6.
    PubMed     Text format     Abstract available
    
    
    
43. GUO L, Zhang W, Sheng Y, Chen K, et al
    Expression and significance of LRIG3 in human cervical squamous cell carcinoma.
    Eur J Gynaecol Oncol. 2015;36:414-9.
    PubMed     Text format     Abstract available
    
    
    
44. CHOI SK, Hong YO, Lee WM, Kim EK, et al
    Overexpression of PI3K-p110alpha in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1.
    Eur J Gynaecol Oncol. 2015;36:389-93.
    PubMed     Text format     Abstract available
    
    
    
45. PYEON SY, Park JY, Ulak R, Seol HJ, et al
    Isolated brain metastasis from uterine cervical cancer: a case report and review of literature.
    Eur J Gynaecol Oncol. 2015;36:602-4.
    PubMed     Text format     Abstract available
    
    
    
46. MUSAEV A, Guzel AB, Khatib G, Gulec UK, et al
    Assessment of primary radical hysterectomy and neoadjuvant chemotherapy followed by radical hysterectomy in Stage IB2, IIA bulky cervical cancer.
    Eur J Gynaecol Oncol. 2015;36:579-84.
    PubMed     Text format     Abstract available
    
    
    
47. CHIAPPETTA C, Lendaro E, Cacciotti J, Zaralli R, et al
    Primary HPV test screening in cervical cancer: a two-year experience of a single screening center in Latina (Italy).
    Eur J Gynaecol Oncol. 2015;36:569-73.
    PubMed     Text format     Abstract available
    
    
    
48. XIE QH, Deng KX, Zheng YH, Wang H, et al
    Modified radical vaginal hysterectomy for cervical cancer treatment.
    Eur J Gynaecol Oncol. 2015;36:554-9.
    PubMed     Text format     Abstract available
    
    
    
49. ABUDOUKADEER A, Niyazi M, Aikula A, Kamilijian M, et al
    Association of EBV and HPV co-infection with the development of cervical cancer in ethnic Uyghur women.
    Eur J Gynaecol Oncol. 2015;36:546-50.
    PubMed     Text format     Abstract available
    
    
    
50. XU Q, Cao X, Pan J, Ye Y, et al
    Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
    Eur J Gynaecol Oncol. 2015;36:539-45.
    PubMed     Text format     Abstract available
    
    
    
51. LI L, Li LY, Hu FJ, Zeng SY, et al
    Pathologic characteristics and prognosis of a rare advanced cervical cancer treated with radical surgery and radiotherapy.
    Eur J Gynaecol Oncol. 2015;36:524-8.
    PubMed     Text format     Abstract available
    
    
    
52. MIHMANLI V, Toprakci G, Cetinkaya N, Kilickaya A, et al
    Primary malignant melanoma of the cervix: a case report.
    Eur J Gynaecol Oncol. 2015;36:607-9.
    PubMed     Text format     Abstract available
    
    
    
53. SUN LL, Chen W, Fan YY, Wang ML, et al
    The presence of advanced lesions and associating risk factors for advanced cervical carcinoma in patients with atypical sguamous cells of undetermined significance.
    Eur J Gynaecol Oncol. 2015;36:585-9.
    PubMed     Text format     Abstract available
    
    
    
54. LIU ZQ, Zhao GQ, Meng W, Zhi GQ, et al
    Effect of biological behavior and clinical significance of maspin gene on cervical squamous carcinoma SiHa cell.
    Eur J Gynaecol Oncol. 2015;36:533-8.
    PubMed     Text format     Abstract available
    
    
    
55. LIU Y, Man SH, Liu X, Ding XY, et al
    Identification of cervical cancer markers using cDNA subtraction approach.
    Eur J Gynaecol Oncol. 2015;36:730-3.
    PubMed     Text format     Abstract available
    
    
    
56. LING S, Ruiqin M, Guohong Z, Bing S, et al
    Decreased microRNA-206 and its function in cervical cancer.
    Eur J Gynaecol Oncol. 2015;36:716-21.
    PubMed     Text format     Abstract available
    
    
    
57. ANGELOPOULOS G, Etman A, Cruickshank DJ, Twigg JP, et al
    Total laparoscopic radical hysterectomy: a change in practice for the management of early stage cervical cancer in a U.K. cancer center.
    Eur J Gynaecol Oncol. 2015;36:711-5.
    PubMed     Text format     Abstract available
    
    
    
58. MZARICO E, Gomez-Roig MD, Guirado L, Lorente N, et al
    Relationship between smoking, HPV infection, and risk of Cervical cancer.
    Eur J Gynaecol Oncol. 2015;36:677-80.
    PubMed     Text format     Abstract available
    
    
    
59. LING W, Zhigang H, Tian H, Bin Z, et al
    HPV 16 infection up-regulates Piwil2, which affects cell proliferation and invasion in cervical cancer by regulating MMP-9 via the MAPK pathway.
    Eur J Gynaecol Oncol. 2015;36:647-54.
    PubMed     Text format     Abstract available
    
    
    
60. ZWIERZCHOWSKA A, Panek G, Gajewska M
    Postradiation carcinosarcoma of the corpus uteri--a case report.
    Eur J Gynaecol Oncol. 2015;36:746-9.
    PubMed     Text format     Abstract available
    
    
    
61. TJALMA WA
    Safety of converting a radical vaginal trachelectomy to a radical hysterectomy during pregnancy.
    Eur J Gynaecol Oncol. 2015;36:734-6.
    PubMed     Text format     Abstract available
    
    
    
62. CHIAPPETTA C, Lendaro E, Cacciotti J, Zaralli R, et al
    The 16, 18, and 45 HPV infection in high grade squamous cervical lesions in primary hr-HPV test screening program.
    Eur J Gynaecol Oncol. 2015;36:722-5.
    PubMed     Text format     Abstract available
    
    
    
63. LI JM, Shao JL, Zeng WJ, Liang RB, et al
    General/epidural anesthesia in combination preserves NK cell activity and affects cytokine response in cervical carcinoma patients undergoing radical resection: a cohort prospective study.
    Eur J Gynaecol Oncol. 2015;36:703-7.
    PubMed     Text format     Abstract available
    
    
    
64. RODRIGUEZ-FLORES A, Nunez-Fernandez G, Estrada-Garcia I, Aguilar-Santelises M, et al
    Adjuvant treatment with a dialyzable leukocytes extract contributes to maintain HPV-infected women free of low-grade cervical lesions.
    Eur J Gynaecol Oncol. 2015;36:655-61.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: